U.S. Electrical Stock News

NasdaqGM:AIRO
NasdaqGM:AIROAerospace & Defense

Could AIRO Group Holdings' Drone Focus and Vertical Integration Redefine Its Defense Narrative (AIRO)?

On March 11, 2026, AIRO Group Holdings, Inc. presented at the Cantor Global Technology & Industrial Growth Conference in New York, with Executive Chairman Chirinjeev Kathuria, CEO Joe Burns, and CFO Mariya Pylypiv outlining the company’s integrated aerospace and defense offering. The focus on defense-oriented drones, proprietary technology and vertically integrated manufacturing, together with R&D and government certifications, underscored AIRO’s effort to build recurring revenue across...
NasdaqGS:ICUI
NasdaqGS:ICUIMedical Equipment

ICU Medical Confronts Revenue Strain As Valuation Signals Potential Upside

ICU Medical, NasdaqGS:ICUI, is dealing with ongoing revenue stagnation and rising capital intensity that point to operational and market pressures. Future sales are projected to decline, alongside shrinking free cash flow margins, highlighting concerns about the company’s ability to convert revenue into cash. These developments are emerging as fresh issues for investors and other stakeholders who follow ICU Medical’s financial and competitive position. ICU Medical’s current share price of...
NYSE:CL
NYSE:CLHousehold Products

Colgate-Palmolive Adds Healthcare CEO To Board And Extends Dividend Streak

Colgate-Palmolive (NYSE:CL) appointed Christopher Boerner, CEO of Bristol-Myers Squibb, to its Board of Directors. Board member Steven Cahillane will not stand for reelection at the company’s upcoming annual meeting. The company also announced its 62nd consecutive annual dividend increase. Colgate-Palmolive, the global consumer products company behind oral care, personal care, and home care brands, is adding a senior healthcare executive to its board at a time when cross-industry expertise...
NasdaqGS:AKAM
NasdaqGS:AKAMIT

Is It Time To Reassess Akamai Technologies (AKAM) After Its Strong Share Price Run?

If you are wondering whether Akamai Technologies is fairly priced or if the recent buzz has left it mispriced, you are in the right place for a closer look at what the current share price might be implying. Akamai's share price closed at US$105.47, with returns of 4.4% over 7 days, 11.7% over 30 days, 23.9% year to date, 34.1% over 1 year and 45.4% over 3 years, while the 5 year return stands at 7.4%. These price moves sit against an ongoing focus on Akamai's role in content delivery and...
NYSE:USFD
NYSE:USFDConsumer Retailing

Is It Too Late To Consider US Foods Holding (USFD) After Its Strong Multi Year Rally?

If you have been wondering whether US Foods Holding is still reasonably priced after its recent run, this article walks through what the numbers actually say about its current value. The stock last closed at US$92.61, with returns of 0.5% over 7 days, 2.1% over 30 days, 24.1% year to date and 45.4% over the past year, while the 3 year and 5 year returns sit at 167.8% and 151.3% respectively. Recent attention on US Foods has been driven by ongoing interest in large foodservice distributors...
NasdaqGS:CRVL
NasdaqGS:CRVLHealthcare

Is CorVel’s (CRVL) Debt-Free Strength a Hidden Edge in Claims Management or Just Prudence?

Recent analysis highlighted that CorVel passed a high-quality investment screen, underpinned by very large returns on invested capital and a debt-free balance sheet in its cost containment and claims management business. This focus on financial strength and operational resilience has drawn attention from investors who prioritize durable business models and conservative balance sheets. Next, we’ll examine how CorVel’s debt-free position shapes its investment narrative in light of the latest...
NYSE:MRK
NYSE:MRKPharmaceuticals

A Look At Merck (MRK) Valuation As Recent Gains Contrast Conflicting Fair Value Estimates

Merck (MRK) is back on investors’ radar after recent trading left the shares around $115.91, with short term returns mixed, while the past 3 months and year have shown stronger overall performance metrics. See our latest analysis for Merck. Short term share price returns for Merck have been soft, but a 15.56% 90 day share price return and 26.99% 1 year total shareholder return suggest momentum has recently been building for long term holders. If Merck’s moves have you reassessing healthcare,...
NYSE:CNK
NYSE:CNKEntertainment

Cinemark Holdings (CNK) Valuation Check After Recent Share Price Pullback And Multi Year Gain

Cinemark Holdings (CNK) shares have been relatively steady recently, with a one-month return near flat and a gain of about 4% over the past three months, prompting investors to reassess the cinema operator’s current valuation and earnings profile. See our latest analysis for Cinemark Holdings. At a share price of US$25.53, Cinemark’s recent moves include a 9.63% 7 day share price pullback alongside an 8.50% year to date share price return and a 3 year total shareholder return above 100%. This...
NYSE:CTRE
NYSE:CTREHealth Care REITs

Assessing CareTrust REIT (CTRE) Valuation After Its Higher Dividend And Growth Confidence

CareTrust REIT (CTRE) is drawing fresh attention after its Board of Directors approved a higher quarterly common stock cash dividend, increasing the payout from $0.335 to $0.39 per share. See our latest analysis for CareTrust REIT. The higher dividend comes after a strong run in the shares, with a 90 day share price return of 10.47% and a 1 year total shareholder return of 50.87%, indicating momentum that long term holders have already experienced. If this dividend move has you looking beyond...
NasdaqGS:PLAB
NasdaqGS:PLABSemiconductor

Assessing Photronics (PLAB) Valuation As AI Photomask Strength Meets Softer Demand And Margin Pressure

Recent commentary around Photronics (PLAB) is being driven by a mix of positives, including record revenue from high-end photomasks and fresh investments in U.S. and South Korean facilities, alongside softer demand, declining sales, and margin pressures. See our latest analysis for Photronics. Despite recent headlines around record high end photomask revenue and new capacity investments, Photronics’ recent share price performance has cooled. The company has a 30 day share price return of...
NasdaqGS:HOOD
NasdaqGS:HOODCapital Markets

Is Robinhood Markets (HOOD) Still Attractive After 7x Gain And Recent Pullback

If you are wondering whether Robinhood Markets at around US$76 per share is priced for perfection or still has room based on fundamentals, you are not alone. The stock has pulled back recently, with a 5.5% decline over the last 7 days and an 11.1% decline over the last 30 days. However, the 1 year return sits at 111.3% and the 3 year gain is very large at around 7x. That swing in sentiment comes as Robinhood stays in the headlines for its role as a major retail trading platform and for...
NasdaqGM:WVE
NasdaqGM:WVEPharmaceuticals

Assessing Wave Life Sciences (WVE) Valuation After WVE-007 Obesity Data And Cash Runway Update

Wave Life Sciences (WVE) drew investor attention after reporting interim Phase I data for its INHBE obesity candidate WVE-007, and detailing a cash position it expects to fund multiple trials and regulatory milestones through 2026. See our latest analysis for Wave Life Sciences. The latest WVE-007 readout and funding runway arrive after a 1-year total shareholder return of about 30% and a very large 3-year total shareholder return, even as the 90-day share price return of a 19.38% decline and...
NasdaqGS:PLTK
NasdaqGS:PLTKEntertainment

Playtika Leadership Shakeup Puts Capital Allocation And Governance In Focus

Playtika Holding (NasdaqGS:PLTK) announced that Chief Financial Officer and President Craig Abrahams will resign effective April 1, 2026. Tae Lee, who has corporate finance experience at Playtika and Meta, will become acting CFO when the change takes effect. Board Chairperson Robert Antokol will also assume the role of President, taking on an expanded leadership position. Playtika operates in the mobile gaming sector, where user engagement, live operations and content updates tend to matter...
NasdaqGS:RUN
NasdaqGS:RUNElectrical

Sunrun (RUN) Valuation Check After Recent Volatility And A 37.3% Undervaluation Narrative

Sunrun (RUN) is back on investors’ radar after recent trading has highlighted how volatile the stock can be, with sharp swings over the past month and past 3 months drawing fresh scrutiny. See our latest analysis for Sunrun. At a share price of US$11.97, Sunrun’s recent 30 day and year to date share price returns of 42.06% and 38.43% declines sit in contrast with a 1 year total shareholder return of 92.75%. This suggests that earlier optimism has cooled while longer term holders still sit on...
NYSE:RLX
NYSE:RLXTobacco

The Bull Case For RLX Technology (RLX) Could Change Following Earnings Growth And Major Share Buyback

RLX Technology Inc. has reported its full-year 2025 results, with revenue of CNY 3,958.86 million and net income of CNY 921.87 million, alongside higher basic and diluted earnings per share from continuing operations compared with 2024. Over the course of its CNY 330 million share repurchase program completed in 2025, RLX bought back 12.71% of its shares, meaning recent profit growth is now spread across a meaningfully smaller share count. With full-year earnings rising and a sizeable...
NYSE:ITGR
NYSE:ITGRMedical Equipment

A Look At Integer Holdings (ITGR) Valuation After Recent Share Price Rebound

Integer Holdings event overview Integer Holdings (ITGR) has drawn fresh attention after recent share price moves, with the stock down about 3% over the past month and up roughly 15% in the past 3 months. See our latest analysis for Integer Holdings. The 1-year total shareholder return decline of 29.65% contrasts with the recent 14.55% 90-day share price return. This suggests momentum has picked up after a weaker stretch for long-term holders at the latest share price of US$83.30. If Integer’s...
NYSE:FLR
NYSE:FLRConstruction

Fluor’s Bucharest Nuclear Push Tests Growth Ambitions And Risk Controls

Fluor (NYSE:FLR) is opening a new office in Bucharest, Romania to support advanced nuclear energy projects in Eastern Europe. The office will focus on major Romanian projects, including the Doicești small modular reactor installation and the expansion of the Cernavodă nuclear power plant. This move reflects Fluor’s broader push into European nuclear infrastructure and clean energy solutions. For you as an investor, the Bucharest office highlights how Fluor is positioning its engineering and...
NasdaqGS:BBIO
NasdaqGS:BBIOBiotechs

How Positive Phase 3 LGMD Data Could Shape BridgeBio Pharma’s (BBIO) Risk Profile and Upside Potential

BridgeBio Pharma recently presented additional positive interim data from its Phase 3 FORTIFY trial of oral BBP-418 in LGMD2I/R9, showing broad efficacy across mobility, biomarker, and subgroup endpoints, along with a safety profile comparable to placebo. These results underpin BridgeBio’s plan to file for US FDA approval in the first half of 2026, positioning BBP-418 as a potential first-ever approved therapy for any form of limb-girdle muscular dystrophy and highlighting the company’s...
NasdaqCM:MBIN
NasdaqCM:MBINDiversified Financial

How Merchants Bancorp’s Government-Backed Lending Strength Will Impact Merchants Bancorp (MBIN) Investors

Merchants Bancorp recently reported quarterly results that exceeded analyst expectations for revenue, earnings per share and net interest income, highlighting continued strength in its low-risk, government-backed lending programs such as multi-family mortgage banking and mortgage warehousing. This earnings beat underscores how the bank’s focus on government-supported credit channels can support business resilience even when broader financial conditions are uncertain. Next, we will examine...
NasdaqGS:NTSK
NasdaqGS:NTSKSoftware

Netskope (NTSK) Q4 Loss Narrows Sharply Challenging Bearish Profitability Narratives

Netskope (NTSK) sets the stage with FY 2026 numbers Netskope (NTSK) has just put fresh FY 2026 figures on the table, with fourth quarter revenue at US$196.3 million and a basic EPS loss of US$0.14, alongside a full year basic EPS loss of US$3.18 on trailing twelve month revenue of US$709.0 million. Over recent quarters the company has seen revenue move from US$148.5 million in Q4 FY 2025 to US$196.3 million in Q4 FY 2026, while quarterly basic EPS has ranged from a loss of US$0.72 to a loss...
NasdaqGS:LSCC
NasdaqGS:LSCCSemiconductor

Is It Too Late To Consider Lattice Semiconductor (LSCC) After Its Strong Multi Year Run

If you are wondering whether Lattice Semiconductor still offers good value after a strong multi year run, this article will walk through what the numbers are indicating about the stock today. The share price recently closed at US$86.40, with returns of 49.0% over 1 year and 96.4% over 5 years. Over the last 7 and 30 days the share price declined 5.2% and 5.0% respectively, while it has gained 9.9% year to date. Recent coverage of Lattice has focused on its position in the semiconductor space...
NYSE:USB
NYSE:USBBanks

A Look At U.S. Bancorp (USB) Valuation After Mixed Q4 Results And Institutional Stake Reductions

What is driving interest in U.S. Bancorp stock right now? U.S. Bancorp (USB) is back in focus after Q4 results that slightly topped revenue expectations but missed tangible book value per share estimates, alongside fresh dividend declarations and visible shifts in institutional ownership. See our latest analysis for U.S. Bancorp. The latest sell off has taken U.S. Bancorp’s share price to US$51.48, with a 1 month share price return of negative 14.98% and a year to date share price return of...
NYSE:YMM
NYSE:YMMTransportation

Full Truck Alliance (NYSE:YMM) Margin Expansion Reinforces Bullish Narratives Despite Modest Growth Forecasts

Full Truck Alliance (NYSE:YMM) just wrapped up FY 2025 with Q4 revenue of C¥3.2b and basic EPS of C¥0.95, capping a twelve month run that produced C¥12.5b in trailing revenue and C¥4.23 in trailing EPS. Over recent periods, revenue has moved from C¥3.2b in Q4 2024 to C¥2.7b in Q1 2025, then between roughly C¥3.2b and C¥3.4b through Q2 to Q4 2025, while quarterly EPS ranged from C¥0.54 in Q4 2024 up to C¥1.22 in Q1 2025. With trailing net income of C¥4.4b and a trailing net margin of 35.3%,...
NYSE:KOS
NYSE:KOSOil and Gas

A Look At Kosmos Energy’s (KOS) Valuation After Its Dilutive Discounted Equity Offering

Kosmos Energy (KOS) has completed a large follow-on equity offering of 97,500,000 common shares at US$1.90, raising about US$185.25 million to repay commercial debt and other outstanding borrowings. See our latest analysis for Kosmos Energy. The follow on offering sits against a sharp rebound in Kosmos Energy’s 90 day share price return of 123.53% and year to date share price return of 155.38%. However, the 3 year total shareholder return is a 64.21% loss, suggesting recent momentum has...